Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 14 symbols : GLAXF save search
Thyroid Gland Disorder Treatment Market Records a CAGR of 4.63% by 2025|35% of Growth to Originate from North America |17000+ Technavio Reports
Published: 2021-12-14 (Crawled : 12:30) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: -3.37%
H: 0.0%
C: 0.0%
VTRS | $11.21 0.81% 2.4M
|
Health Technology
|
| O: -0.4%
H: 4.78%
C: 2.07%
GSK | $39.585 0.8% 1.1M
|
Health Technology
|
| O: -0.77%
H: 0.6%
C: 0.23%
ABBV | News | $165.97 0.8% 3.1M
|
Health Technology
|
| O: 0.49%
H: 0.0%
C: 0.0%
ABT | News | $106.76 1.42% 3.8M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.22%
H: 1.65%
C: 1.15%
treatment order growth
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.